Summary.-Experiments were conducted to determine whether the histological pattern of tumour growth of hormone-responsive MCF-7 human mammary adenocarcinoma varied in different tissues of athymic mice. Tumours in the uterus following intrauterine injection were rapidly proliferating and highly invasive. Tumours injected intracerebrally were also highly invasive. In contrast, s.c. tumours and those which arose in the lung following intrapleural injection, grew as small localized nodules without evidence of aggressive invasion of surrounding tissues. These findings indicate that selective implantation of human tumours in athymic mice can be used to develop different models of tumour growth and aggressiveness.
THERE HAS BEEN a continuing effort to develop new models of clinical neoplasia using human tumours xenografted into athymic mice. Historically, almost all these attempts have involved the subcutaneum as the site of tumour implantation. Often these s.c. tumours produce only small, slow-growing non-invasive lesions. Clinically such tumours are rarely life-threatening and are generally manageable by surgical and/or radiological intervention. Although, experimentally, s.c. tumours with this slow, non-aggressive pattern of growth may be of interest in studies of tumour nidation, vascularization or other early tumour behaviour, they do not mimic the life-threatening aspect of visceral metastatic disease.
Visceral metastatic tumours may produce large invasive tumour burdens that kill the host. It is this aggressive form of the disease which is the subject of most trials of new therapies (Phase II trials). Therefore new xenograft models should be developed which reflect advanced disease.
One method of developing xenograft models of visceral metastatic disease is to implant the human tissue at sites that more closely reflect their tissue of origin, or sites at which a particular tumour type is predicted to metastasize. Compared to simple s.c. implantation, manipulations of this type might be expected to reflect more closely the biological potential of human tumours. In this paper we report on the divergent growth characteristics of the human hormone-responsive MCF-7 mammary-tumour cell line in different tissues of the athmyic mouse. The MCF-7 cell line was established from a pleural effusion in a patient diagnosed with a primary mammary carcinoma and contains oestrogen receptors (Brooks et al., 1973) . The conditions under which the MCF-7 cell line will grow in athymic mice have recently been partly elucidated. In normal female athymic mice without hormone supplementation MCF-7 cells injected s.c. do not grow progressively. However, when MCF-7 cells are implanted s.c. in athymic mice receiving ectopic oestradiol (Soule & McGrath, 1980) or pituitary transplants (Russo et al., 1977; Ozzello & Sordat, 1980) progressive tumour growth ensues. Given this difference in growth patterns, and observations that these cells contain receptors for the major steroid sex hormones (Brooks et al., 1973; Horwitz et al., 1975; Lippman et al., 1976) [2,4,6,7-3H(N) ]-oestradiol (101-7 Ci/mmol, New England Nuclear) and killed by exsanguination 60 min later. Tissue specimens of lung, uterus, periovarian fat with oviducts, whole brain, subcutaneum and liver were excised, washed in cold saline and frozen. To determine the ability of these organs to take up hormone and retain non-metabolized oestradiol the samples were homogenized, ether-extracted and chromatographed. Immediately after homogenization, aliquots of each tissue were solubilized in aquasol (New England Nuclear) and the amount of oestradiol taken up determined by liquid-scintillation counting. Nonmetabolized oestradiol remaining in the tissue was determined by paper chromatography. Ether extracts of the homogenized tissues were evaporated and redissolved in 100 pl methanol. Samples were spotted on SA sheets (Gelman) and chromatographed in 97:3 chloroform-methanol, along with a purified oestradiol standard. Chromatographs were visualized with the aid of iodine vapour. Spots co-migrating with the oestradiol standard were cut out, iodine allowed to revaporize, then eluted into 1 ml ethanol. Samples were then mixed with a toluene-PPO-POPOP fluor, and radioactive oestradiol determined.
The protein content of the specimens were determined using Coomassie Blue dye (Biorad) as described by Bradford (1976) .
RESULTS
In order to determine the growth characteristics of MCF-7 tumours in diverse murine host tissues, tumour cells were injected into the brain, uterus, pleural cavity or subcutaneum of athymic mice. Three weeks later the mice were killed and the extent of tumour mass was determined grossly and histologically (Table I) . We observed that as early as 21 days after intrauterine injection of MCF-7 cells, 100% (6/6) and 37% (3/8) of mice that receive oestrogen or placebo implants respectively developed large tumours. In these experiments uterine tumour weights were corrected for oestradiol-induced hypertrophy or basal uterine weights. Control females implanted with placebo silastic had uterine weights of 28 + 18 mg. Three weeks after insertion of oestradiol implants, control mice had serum oestrogen levels > 1 ng/ml and uterine wet weights of 140 + 55 mg. Average tumour masses, when corrected for the appropriate uterine weight, were 800 + 172 mg and 650 + 220 mg for oestradiol and placebo treatments respectively. Tumours in both oestradiol-supplemented and placeboimplanted mice were highly invasive and periuterine, involving the uterus, ovary, oviducts and periovarian fat. On histological evaluation, uterine invasion exhibited 3 distinct patterns: en bloc, in clusters and as finger-like projections (Indian-file) into uterine tissue. The cluster form of uterine invasion is shown in Fig. 1 and the Indian-file form in Fig. 2 . The most agressive periuterine tumours also invaded adjacent peritoneal muscle (Fig. 3) but neither kidney or hepatic invasion was noted.
The growth pattern of MCF-7 cells injected into the brains of oestradiolsupplemented athymic mice was similar to that found in uteri and its neighbouring fat. Although gross tumour was not visible at necropsy, widespread tumours were found in histological sections from all the mice (6/6). In all cases tumour growth was evident throughout the ventricular spaces, and diffusely invasive into the cerebrum (Fig. 4) . The intracerebral tumours we observed had poorly defined limits, and appeared to project indiscriminately into cortical white matter.
The intracerebral growth of MCF-7 tumours was not directly related to the brain's position as an immunoprivileged site, since 8 weeks after MCF-7 inoculation no cells were detected in the brains of either 20 male or 20 female nu/nu heterozygous mice. Likewise, no malignancy was detected in 6 male homozygous nude mice, indicating thatreven in the cerebral site MCF-7 tumourigenesis is hormonedependent.
In contrast to the aggressive growth patterns in the brain and uterus, s.c. (Table I) and no invasion beyond the subcutaneous tissue was seen (Fig. 5) . At 3 weeks after tumour-cell implant tumour weights ranged from 5 to 60 mg. Similarly, only 1/6 mice receiving intrapleural tumour-cell injections exhibited a tumour focus. The lobe contained one grossly visible tumour mass 1-2 mm in diameter that was noninvasive on histological examination (Fig.  6 ). Histological preparations revealed no additional microscopic tumour foci.
MCF-7 tumours grew slowly
Analysis of the oestradiol content of tissues exhibiting various patterns of tumour growth suggests a relationship between invasive properties and nonmetabolized hormone levels in the tumour's microenvironment. Table II Non-invasive growth patterns appear in microenvironments characterized by low hormone-concentrating ability.
DISCUSSION
The AICF-7 tumour-cell line produced tumours at selected visceral sites that differed markedly in their patterns of growth. Differences were observed in both the size of the tumour and its invasion of the implantation site and adjacent tissues. Clinically these parameters of growth rate, site of involvement and degree of invasion represent the hallmarks distinguishing resectable, potentially curable disease to disseminated, aggressive disease of morbid consequence. These studies reinforce the observation of complex interactions bet-oestrogen to produce tumours in vivo, ween the tumour and its host tissues to we have studied the effect of this variable determine which disease type will be on tumour growth patterns at different manifested.
implantation sites. The uterus, perioBecause the MCF-7 cell line requires varian fat and brain can concentrate (Soule & McGrath, 1980; Russo et al., 1977 , Ozello & Sordat, 1980 The importance of specific tissue susceptibility to invasion is further demonstrated by our observation of differences in tumour involvement between tissues adjacent to grossly invasive uterine tumours. Adjacent peritoneal muscle became involved with invasive tumours (Fig. 3) but neither kidney nor liver did so. This finding is in basic agreement with previous observations that MCF-7 tumours did not produce hepatic or kidney metastases (Russo et al., 1977; Soule & McGrath, 1980; Ozzello & Sordat, 1980) . However, there was a single report by Shafie & Liotta (1980) of a high rate (60%) of splenic, pleural and hepatic metastases from s.c. MCF-7 primary tumours. Given previous reports cited above on the low metastatic rate for this tumour, and the general observation that metastatic rates in adult athymic mice are very low (Reygarrd, 1973; Sordat et al., 1977;  Wynn-Williams & McCulloch, 1977; Giovannella et al., 1978) we conclude that important differences may exist between Shafie & Liotta's athymic mice or cell lines and our own. Despite these differences, we have observed that sites such as uterus may permit the development of highly aggressive tumours with selective invasion of surrounding tissues. This indicates that there is an intimate relationship between tumour and host tissue in generating a combination that permits violation of the borders of the normal tissue.
Clearly a great deal of work is needed to characterize the host-tumour-steroid relationship. The experiments reported here serve to document the observation that local microenvironment of the host may markedly modulate the rate and pattern of tumour growth. Further, the technique of implantation of hormonally responsive mammary tumours into hormonally responsive host tissue may serve as a model for the study of these interactions. In addition, the use of these techniques may provide one step in the attempt to improve the number of successful primary xenografts from human mammary tumours.
